Ketogenic diets in the treatment of epilepsy

Current Pharmaceutical Design

Volumn 23, Issue 37, 2017, Pages 5691-5701

  Elia, Maurizio ^a   Klepper, Joerg ^b   Leiendecker, Baerbel ^c   Hartmann, Hans ^d  

^a OASI RESEARCH INSTITUTE IRCCS   (Italy)

^b KLINIKUM ASCHAFFENBURG   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Adults; Children; Drug resistant epilepsy; Glut1 deficiency; Ketogenic diets; Pyruvate dehydrogenase deficiency

Indexed keywords

GLUCOSE TRANSPORTER 1; PYRUVATE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADVERSE EVENT; ATONIC SEIZURE; BONE DENSITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG RESISTANT EPILEPSY; EPILEPSY; EPILEPTIC STATE; FATTY LIVER; GASTROINTESTINAL SYMPTOM; GENERALIZED EPILEPSY; HUMAN; HYPERCALCIURIA; HYPERLIPIDEMIA; INFANTILE SPASM; KETOGENIC DIET; METABOLIC DISORDER; MYOCLONUS EPILEPSY; NEPHROLITHIASIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAFETY; ANIMAL; DIET THERAPY;

ANIMALS; DIET, KETOGENIC; EPILEPSY; HUMANS;

EID: 85042096764     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612823666170809101517     Document Type: Review

References (96)

1. Geyelin HR. Fasting as a method for treating epilepsy. Med Rec 1921; 99: 1037-9.
2. Peterman MG. The ketogenic diet in the treatment of epilepsy: A preliminary report. Am J Dis Child 1924; 28: 28-33.
3. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325(10): 703-9.
4. Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: An update for child neurologists. J Child Neurol 2009; 24(8): 979-88.
5. Kossoff EH, Laux LC, Blackford R, et al. When do seizures usually improve with the ketogenic diet? Epilepsia 2008; 49(2): 329-33.
6. Verrotti A, Iapadre G, Pisano S, Coppola G. Ketogenic diet and childhood neurological disorders other than epilepsy: An overview. Expert Rev Neurother 2017; 17(5): 461-73.
7. Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: A review of the therapeutic uses of very-low-carbohydrate (keto-genic) diets. Eur J Clin Nutr 2013; 67(8): 789-96.
8. Bough KJ, Rho JM. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 2007; 48(1): 43-58.
9. Leen WG, Wevers RA, Kamsteeg EJ, Scheffer H, Verbeek MM, Willemsen MA. Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: A systematic review. JAMA Neurol 2013; 70(11): 1440-4.
10. Klepper J. Absence of SLC2A1 mutations does not exclude Glut1 deficiency syndrome. Neuropediatrics 2013; 44(4): 235-6.
11. Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133(Pt 3): 655-70.
12. De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: Current state of the art. Seizure 2013; 22(10): 803-11.
13. Fujii T, Ito Y, Takahashi S, et al. Outcome of ketogenic diets in GLUT1 deficiency syndrome in Japan: A nationwide survey. Brain Dev 2016; 38(7): 628-37.
14. Amalou S, Gras D, Ilea A, et al. Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 2016; 58(11): 1193-9.
15. Wexler ID, Hemalatha SG, McConnell J, et al. Outcome of pyruvate dehydrogenase deficiency treated with ketogenic diets. Studies in patients with identical mutations. Neurology 1997; 49(6): 1655-61.
16. Sofou K, Dahlin M, Hallböök T, Lindefeldt M, Viggedal G, Darin N. Ketogenic diet in pyruvate dehydrogenase complex deficiency: Short- and long-term outcomes. J Inherit Metab Dis 2017; 40(2): 237-45.
17. Kang HC, Lee YM, Kim HD, Lee JS, Slama A. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007; 48(1): 82-8.
18. Geyelin HR. Fasting as a method for treating epilepsy. Med Rec 1921; 99: 1037-9.
19. Neal EG, Chaffe H, Schwartz RH, et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009; 50(5): 1109-17.
20. Bergqvist AG, Schall JI, Gallagher PR, Cnaan A, Stallings VA. Fasting versus gradual initiation of the ketogenic diet: A prospective, randomized clinical trial of efficacy. Epilepsia 2005; 46(11): 1810-9.
21. Kossoff EH, Cervenka MC, Henry BJ, Haney CA, Turner Z. A decade of the modified Atkins diet (2003–2013): Results, insights, and future directions. Epilepsy Behav 2013; 29(3): 437-42.
22. Kossoff EH, Zupec-Kania BA, Amark PE, et al. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009; 50(2): 304-17.
23. Sampath A, Kossoff EH, Furth SL, Pyzik PL, Vining EP. Kidney stones and the ketogenic diet: risk factors and prevention. J Child Neurol 2007; 22(4): 375-8.
24. Neal EG, Zupec-Kania B, Pfeifer HH. Carnitine, nutritional sup-plementation and discontinuation of ketogenic diet therapies. Epilepsy Res 2012; 100(3): 267-71.
25. Kossoff EH, Dorward JL. The modified Atkins diet. Epilepsia 2008; 49(Suppl. 8): 37-41.
26. Worden LT, Turner Z, Pyzik PL, Rubenstein JE, Kossoff EH. Is there an ideal way to discontinue the ketogenic diet? Epilepsy Res 2011; 95(3): 232-6.
27. Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 1998; 102(6): 1358-63.
28. Klepper J, Leiendecker B. Glut1 deficiency syndrome and novel ketogenic diets. J Child Neurol 2013; 28(8): 1045-8.
29. Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev 2016; 2: CD001903.
30. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia 2010; 51(4): 676-85.
31. Geyelin HR. Fasting as a method for treating epilepsy. Med Rec 1921; 99: 1037-9.
32. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30(4): 389-99.
33. Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: A randomised controlled trial. Lancet Neurol 2008; 7(6): 500-6.
34. Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: A randomized controlled trial. Epilepsia 2013; 54(3): 481-6.
35. Kossoff EH, Turner Z, Bluml RM, Pyzik PL, Vining EP. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav 2007; 10(3): 432-6.
36. El-Rashidy OF, Nassar MF, Abdel-Hamid IA, et al. Modified Atkins diet vs classic ketogenic formula in intractable epilepsy. Acta Neurol Scand 2013; 128(6): 402-8.
37. Raju KN, Gulati S, Kabra M, et al. Efficacy of 4:1 (classic) versus 2.5:1 ketogenic ratio diets in refractory epilepsy in young children: a randomized open labeled study. Epilepsy Res 2011; 96(1-2): 96-100.
38. Kim JA, Yoon JR, Lee EJ, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 2016; 57(1): 51-8.
39. Arsov T, Mullen SA, Damiano JA, et al. Early onset absence epilepsy: 1 in 10 cases is caused by GLUT1 deficiency. Epilepsia 2012; 53(12): e204-7.
40. Arsov T, Mullen SA, Rogers S, et al. Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. Ann Neurol 2012; 72(5): 807-15.
41. Schoeler NE, Cross JH, Drury S, et al. Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor. Dev Med Child Neurol 2015; 57(10): 969-76.
42. Becker F, Schubert J, Weckhuysen S, et al. Do Glut1 (glucose transporter type 1) defects exist in epilepsy patients responding to a ketogenic diet? Epilepsy Res 2015; 114: 47-51.
43. Della Marina A, Leiendecker B, Wiemer-Kruel A, et al. Ketogene Ernährungstherapien: Welche Variante für welchen Patienten? Neuropädiatrie in Klinik und Praxis 2016; 15: 44-51.
44. Hong AM, Turner Z, Hamdy RF, Kossoff EH. Infantile spasms treated with the ketogenic diet: prospective single-center experience in 104 consecutive infants. Epilepsia 2010; 51(8): 1403-7.
45. Caraballo R, Vaccarezza M, Cersósimo R, et al. Long-term follow-up of the ketogenic diet for refractory epilepsy: multicenter Argen-tinean experience in 216 pediatric patients. Seizure 2011; 20(8): 640-5.
46. Nabbout R, Copioli C, Chipaux M, et al. Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study. Epilepsia 2011; 52(7): e54-7.
47. Oguni H, Tanaka T, Hayashi K, et al. Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood. Neuropediatrics 2002; 33(3): 122-32.
48. Bergqvist AG. Myoclonic astatic epilepsy and the use of the ketogenic diet. Epilepsy Res 2012; 100(3): 258-60.
49. Wiemer-Kruel A, Haberlandt E, Hartmann H, Wohlrab G, Bast T. Modified Atkins diet is an effective treatment for children with Doose syndrome. Epilepsia 2017; 58(4): 657-62.
50. Stenger E, Schaeffer M, Cances C, et al. Efficacy of a ketogenic diet in resistant myoclono-astatic epilepsy: A French multicenter retrospective study. Epilepsy Res 2017; 131: 64-9.
51. Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010; 51(10): 2033-7.
52. van Baalen A, Vezzani A, Häusler M, Kluger G. Febrile Infection-Related Epilepsy Syndrome: Clinical Review and Hypotheses of Epileptogenesis. Neuropediatrics 2017; 48(1): 5-18.
53. Appavu B, Vanatta L, Condie J, Kerrigan JF, Jarrar R. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure 2016; 41: 62-5.
54. Farias-Moeller R, Bartolini L, Pasupuleti A, Brittany Cines RD, Kao A, Carpenter JL. A Practical Approach to Ketogenic Diet in the Pediatric Intensive Care Unit for Super-Refractory Status Epilepticus. Neurocrit Care 2017; 26(2): 267-72.
55. Curatolo P, Jóźwiak S, Nabbout R. Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations. Eur J Paediatr Neurol 2012; 16(6): 582-6.
56. Coppola G, Klepper J, Ammendola E, et al. The effects of the ketogenic diet in refractory partial seizures with reference to tuberous sclerosis. Eur J Paediatr Neurol 2006; 10(3): 148-51.
57. Thompson L, Fecske E, Salim M, Hall A. Use of the ketogenic diet in the neonatal intensive care unit-Safety and tolerability. Epilepsia 2017; 58(2): e36-9.
58. Caraballo RH, Valenzuela GR, Armeno M, Fortini S, Mestre G, Cresta A. The ketogenic diet in two paediatric patients with refractory myoclonic status epilepticus. Epileptic Disord 2015; 17(4): 491-5.
59. Coppola G, Veggiotti P, Cusmai R, et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: An Italian multicentric experience. Epilepsy Res 2002; 48(3): 221-7.
60. Arslan N, Guzel O, Kose E, et al. Is ketogenic diet treatment hepa-totoxic for children with intractable epilepsy? Seizure 2016; 43: 32-8.
61. Nizamuddin J, Turner Z, Rubenstein JE, Pyzik PL, Kossoff EH. Management and risk factors for dyslipidemia with the ketogenic diet. J Child Neurol 2008; 23(7): 758-61.
62. Ozdemir R, Kucuk M, Guzel O, Karadeniz C, Yilmaz U, Mese T. Does ketogenic diet have any negative effect on cardiac systolic and diastolic functions in children with intractable epilepsy?: One-year follow-up results. Brain Dev 2016; 38(9): 842-7.
63. Bergqvist AG, Schall JI, Stallings VA, Zemel BS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr 2008; 88(6): 1678-84.
64. Bertoli S, Trentani C, Ferraris C, De Giorgis V, Veggiotti P, Tagli-abue A. Long-term effects of a ketogenic diet on body composition and bone mineralization in GLUT-1 deficiency syndrome: a case series. Nutrition 2014; 30(6): 726-8.
65. Barborka C. Epilepsy in adults: results of treatment by ketogenic diet in one hundred cases. Arch Neurol 1930; 6: 904-14.
66. Sirven J, Whedon B, Caplan D, et al. The ketogenic diet for intractable epilepsy in adults: Preliminary results. Epilepsia 1999; 40(12): 1721-6.
67. Kossoff EH, Turner Z, Bergey GK. Home-guided use of the ketogenic diet in a patient for more than 20 years. Pediatr Neurol 2007; 36(6): 424-5.
68. Mosek A, Natour H, Neufeld MY, Shiff Y, Vaisman N. Ketogenic diet treatment in adults with refractory epilepsy: a prospective pilot study. Seizure 2009; 18(1): 30-3.
69. Klein P, Janousek J, Barber A, Weissberger R. Ketogenic diet treatment in adults with refractory epilepsy. Epilepsy Behav 2010; 19(4): 575-9.
70. Lambrechts DA, Wielders LH, Aldenkamp AP, Kessels FG, de Kinderen RJ, Majoie MJ. The ketogenic diet as a treatment option in adults with chronic refractory epilepsy: efficacy and tolerability in clinical practice. Epilepsy Behav 2012; 23(3): 310-4.
71. Nei M, Ngo L, Sirven JI, Sperling MR. Ketogenic diet in adolescents and adults with epilepsy. Seizure 2014; 23(6): 439-42.
72. Kossoff EH, Rowley H, Sinha SR, Vining EP. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia 2008; 49(2): 316-9.
73. Carrette E, Vonck K, de Herdt V, et al. A pilot trial with modified Atkins’ diet in adult patients with refractory epilepsy. Clin Neurol Neurosurg 2008; 110(8): 797-803.
74. Smith M, Politzer N, Macgarvie D, McAndrews MP, Del Campo M. Efficacy and tolerability of the modified Atkins diet in adults with pharmacoresistant epilepsy: a prospective observational study. Epilepsia 2011; 52(4): 775-80.
75. Cervenka MC, Terao NN, Bosarge JL, et al. E-mail management of the modified Atkins Diet for adults with epilepsy is feasible and effective. Epilepsia 2012; 53(4): 728-32.
76. Kossoff EH, Henry BJ, Cervenka MC. Efficacy of dietary therapy for juvenile myoclonic epilepsy. Epilepsy Behav 2013; 26(2): 162-4.
77. Kverneland M, Selmer KK, Nakken KO, Iversen PO, Taubøll E. A prospective study of the modified Atkins diet for adults with idiopathic generalized epilepsy. Epilepsy Behav 2015; 53: 197-201.
78. Cervenka MC, Patton K, Eloyan A, Henry B, Kossoff EH. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr Neurosci 2016; 19(3): 131-7.
79. Schoeler NE, Wood S, Aldridge V, Sander JW, Cross JH, Sisodiya SM. Ketogenic dietary therapies for adults with epilepsy: Feasibility and classification of response. Epilepsy Behav 2014; 37: 77-81.
80. Cervenka MC, Henry BJ, Felton EA, Patton K, Kossoff EH. Establishing an adult epilepsy diet center: experience, efficacy and challenges. Epilepsy Behav 2016; 58: 61-8.
81. Ebus SC, Lambrechts DA, Herraets IJ, et al. Can an early 24-hour EEG predict the response to the ketogenic diet? A prospective study in 34 children and adults with refractory epilepsy treated with the ketogenic diet. Seizure 2014; 23(6): 468-74.
82. Cervenka MC, Henry B, Nathan J, Wood S, Volek JS. Worldwide dietary therapies for adults with epilepsy and other disorders. J Child Neurol 2013; 28(8): 1034-40.
83. Ye F, Li XJ, Jiang WL, Sun HB, Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol 2015; 11(1): 26-31.
84. Martikainen MH, Päivärinta M, Jääskeläinen S, Majamaa K. Successful treatment of POLG-related mitochondrial epilepsy with antiepileptic drugs and low glycaemic index diet. Epileptic Disord 2012; 14(4): 438-41.
85. Matsuzono K, Kurata T, Deguchi S, Yamashita T, Deguchi K, Abe K. Ketogenic diet therapy is effective in encephalitis with refractory seizures. Neurol Res 2014; 36(10): 906-10.
86. Leen WG, Taher M, Verbeek MM, Kamsteeg EJ, van de Warren-burg BP, Willemsen MA. GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol 2014; 261(3): 589-99.
87. Bodenant M, Moreau C, Sejourné C, et al. [Interest of the ketogenic diet in a refractory status epilepticus in adults]. Rev Neurol (Paris) 2008; 164(2): 194-9.
88. Nam SH, Lee BL, Lee CG, et al. The role of ketogenic diet in the treatment of refractory status epilepticus. Epilepsia 2011; 52(11): e181-4.
89. Cervenka MC, Hartman AL, Venkatesan A, Geocadin RG, Kossoff EH. The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit. Neurocrit Care 2011; 15(3): 519-24.
90. Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014; 82(8): 665-70.
91. Cervenka MC, Hocker S, Koenig M, et al. Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus. Neurology 2017; 88(10): 938-43.
92. Schoeler NE, Cross JH. Ketogenic dietary therapies in adults with epilepsy: a practical guide. Pract Neurol 2016; 16(3): 208-14.
93. Gruenthal M. Comment: should we induce ketosis in super-refractory status epilepticus? Neurology 2014; 82(8): 669.
94. Gruenthal M. Comment: should we induce ketosis in super-refractory status epilepticus? Neurology 2014; 82(8): 669.
95. Gruenthal M. Comment: should we induce ketosis in super-refractory status epilepticus? Neurology 2014; 82(8): 669.
96. Schoeler NE, Cross JH, Sander JW, Sisodiya SM. Can we predict a favourable response to Ketogenic Diet Therapies for drug-resistant epilepsy? Epilepsy Res 2013; 106(1-2): 1-16.